Jun
10
Tue
Cancer Education Seminar Series: Recent advances in the treatment of elderly patients with AML @ Stanford Cancer Center CC 2103-2104
Jun 10 @ 8:00 am – 9:00 am
Cancer Education Seminar Series: Recent advances in the treatment of elderly patients with AML @ Stanford Cancer Center CC 2103-2104

Presenter: Bruno Medeiros, MD, Assistant Professor of Medicine (Hematology)

Jun
17
Tue
Cancer Education Seminar Series: Molecular Biology of MPNs: Impact on Diagnosis, Prognosis, and Treatment @ Stanford Cancer Center CC 2103-2104
Jun 17 @ 8:00 am – 9:00 am
Cancer Education Seminar Series: Molecular Biology of MPNs: Impact on Diagnosis, Prognosis, and Treatment @ Stanford Cancer Center CC 2103-2104

Presenter: Jason Gotlib, MD, Associate Professor of Medicine (Hematology)

Jun
24
Tue
Cancer Education Seminar Series: Case-based approach to anticoagulation management @ Stanford Cancer Center CC 2103-2104
Jun 24 @ 8:00 am – 9:00 am
Cancer Education Seminar Series: Case-based approach to anticoagulation management @ Stanford Cancer Center CC 2103-2104

Presenter: Caroline Berube, Clinical Associate Professor of Medicine (Hematology)

Jun
16
Tue
Cancer Education Seminar: New Educational Aspects in Acute Myeloid Leukemia @ Stanford Cancer Center CC 2103-2104
Jun 16 @ 8:00 am – 9:00 am
Cancer Education Seminar: New Educational Aspects in Acute Myeloid Leukemia @ Stanford Cancer Center CC 2103-2104

Presenter: Bruno Medeiros, MD, Associate Professor of Medicine (Hematology)

Jun
23
Tue
Cancer Education Seminar: Recent Molecular and Clinical Advances in Myelodysplastic Syndrome @ Stanford Cancer Center CC 2103-2104
Jun 23 @ 8:00 am – 9:00 am
Cancer Education Seminar: Recent Molecular and Clinical Advances in Myelodysplastic Syndrome @ Stanford Cancer Center CC 2103-2104

Presenter: Peter Greenberg, MD, Professor (Emeritus) of Medicine (Hematology)

Jun
30
Tue
Cancer Education Seminar: Updates on Myeloma @ Stanford Cancer Center CC 2103-2104
Jun 30 @ 8:00 am – 9:00 am
Cancer Education Seminar: Updates on Myeloma @ Stanford Cancer Center CC 2103-2104

Presenter: Michaela Liedtke, MD, Assistant Professor of Medicine (Hematology)

Jul
25
Wed
Medicine Grand Rounds: Engineering T Cells for Cancer Therapy @ LKSC Berg Hall
Jul 25 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Engineering T Cells for Cancer Therapy @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: Crystal Mackall, MD
Professor of Pediatric Hematology/Oncology and Medicine                                                          Stanford University

Crystal L Mackall MD is Endowed Professor of Pediatrics and Internal Medicine at Stanford University. She serves as Founding Director of the Stanford Center for Cancer Cell Therapy, Associate Director of Stanford Cancer Institute, Leader of the Cancer Immunology and Immunotherapy Program at Stanford and Director of the Parker Institute for Cancer Immunotherapy at Stanford. During her tenure as Head of the Immunology Section and Chief of the Pediatric Oncology Branch, NCI, she built an internationally recognized translational research program spanning basic studies of T cell homeostasis and tumor immunology, and clinical trials of immune based therapies for cancer. Her work is credited with identifying an essential role for the thymus in human T cell regeneration and discovering IL-7 as the master regulator of T cell homeostasis. She has led numerous cutting edge and first-in-human and first-in-child clinical trials spanning dendritic cell vaccines, cytokines, and adoptive immunotherapy using NK cells and genetically modified T cells. Her group was among the first to demonstrate impressive activity of CD19-CAR in pediatric leukemia and recently demonstrated impressive activity of a second CAR targeting CD22.. Dr. Mackall’s clinical trials are notable for the incorporation of deep biologic endpoints that further our understanding of the basis for success and failure of the agent under study. She has published over 175 manuscripts and serves in numerous leadership positions, including Leader of the NCI Pediatric Cancer Immunotherapy Trials Network, co-Leader of the St. Baldrick’s-StandUp2Cancer Pediatric Dream Team. She is Board Certified in Pediatrics and Internal Medicine.